Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm? A randomized, single-blind, crossover trial

European Neurology

Volumn 65, Issue 5, 2011, Pages 286-290

  Colakoglu, Beril Donmez ^a   Cakmur, Raif ^a   Uzunel, Fatma ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Botulinum toxin; Facial muscles; Hemifacial spasm

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; FACE MUSCLE; FACIAL NERVE PARALYSIS; FEMALE; HEMIFACIAL SPASM; HUMAN; MALE; ORBICULARIS OCULI MUSCLE; ORBICULARIS ORIS MUSCLE; PRIORITY JOURNAL; PTOSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; VISUAL ANALOG SCALE;

AGED; BOTULINUM TOXINS, TYPE A; CROSS-OVER STUDIES; FACIAL MUSCLES; FEMALE; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAIN MEASUREMENT; SINGLE-BLIND METHOD;

EID: 79955116958     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000327534     Document Type: Article

References (17)

1. Wang A, Jankovic J: Hemifacial spasm: Clinical findings and treatment. Muscle Nerve 1998; 21: 1740-1747. (Pubitemid 28545706)
2. Flanders M, Chin D, Boghen D: Botulinum toxin: Preferred treatment for hemifacial spasm. Eur Neurol 1993; 33: 316-319. (Pubitemid 23210366)
3. Jost WH, Kohl A: Botulinum toxin: Evidence- based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 2001; 248(suppl 1):21-24.
4. Simpson DM, Blitzer A, Brashear A, Comel - la C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y: Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence- based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70: 1699-1706. (Pubitemid 351644138)
5. Yoshimura DM, Aminoff MJ, Tami TA, Scott AB: Treatment of hemifacial spasm with botulinum toxin. Muscle Nerve 1992; 15: 1045-1049.
6. Eleopra R, Tugnoli V, Caniatti L, De Grandis D: Botulinum toxin treatment in the facial muscles of humans: Evidence of an action in untreated near muscles by peripheral local diffusion. Neurology 1996; 46: 1158-1160. (Pubitemid 26134671)
7. Ishikawa M, Takashima K, Kamochi H, Kusaka G, Shinoda S, Watanabe E: Treatment with botulinum toxin improves the hyper - excitability of the facial motoneuron in patients with hemifacial spasm. Neurol Res 2010; 32: 656-660.
8. Defazio G, Abbruzzese G, Girlanda P, Vacca L, Curra A, De Salvia R, Marchese R, Raineri R, Roselli F, Livrea P, Berardelli A: Botulinum toxin a treatment for primary hemifacial spasm. Arch Neurol 2002; 59: 418-420.
9. Jitpimolmard S, Tiamkao S, Laopaiboon M: Long-term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: A report of 175 cases. J Neurol Neurosurg Psychiatry 1998; 64: 751-757. (Pubitemid 28274409)
10. Bentivoglioa AR, Fasanoa A, Ialongoa T, Soletia F, Lo Fermob S, Albanese A: Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm. Eur J Neurol 2009; 16: 392-398.
11. Cakmur R, Ozturk V, Uzunel F, Donmez B, Idiman F: Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neurol 2002; 249: 64-68. (Pubitemid 34119025)
12. Elston SJ: Botulinum toxin treatment of hemifacial spasm. J Neurol Neurosurg Psychiatry 1986; 49: 827-829.
13. Kollewe K, Mohammadi B, Dengler R, Dressler D: Hemifacial spasm and reinnervation synkinesias: Long-term treatment with either Botox or Dysport. J Neural Transm 2010; 117: 759-763.
14. Chen RS, Lu CS, Tsai CH: Botulinum toxin A injection in the treatment of hemifacial spasm. Acta Neurol Scand 1996; 94: 207-211.
15. Quagliato EMAB, Carelli EF, Viana MA: Prospective, randomized, double-blind study, comparing botulinum toxins type A Botox and Prosigne for blepharospasm and hemifacial spasm treatment. Clin Neuropharmacol 2010; 33: 27-31.
16. Ogawara K, Kuwabara S, Kamitsukasa I, Mizobuchi K, Misawa S, Hattori T: Trigeminal afferent input alters the excitability of facial motoneurons in hemifacial spasm. Neurology 2004; 62: 1749-1752. (Pubitemid 38661729)
17. Lorenzano C, Bagnato S, Glio F, Fabbrini G, Berardelli A: No clinical or neurophysiologial evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm. Neurotox Res 2006; 9: 141-144.